Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg as an Oral Contraceptive: A Viewpoint by Paula Bednarek

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.16, 2007-01, pp. : 2478-2479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg: As an Oral Contraceptive

By Wagstaff Antona J.

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2473-2477

Adis International

Access to resources Recommend Favorite

User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice: A Multi-Country, Questionnaire-Based Study

By Short Mary

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite

Ethinylestradiol/levonorgestrel: continuous comparable to cyclic

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Low-Dose Ethinylestradiol/Levonorgestrel: A Viewpoint by Luis Bahamondes

By Bahamondes Luis

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2307-2308

Adis International

Access to resources Recommend Favorite

Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg: A Pooled Analysis

By Anttila Leena

Clinical Drug Investigation, Vol. 31, Iss. 8, 2011-08 ,pp. : 519-525

Adis International

Access to resources Recommend Favorite